Clinical trial Recruiting at 1 site Interventional Ages 6 Months to 5

Improving treatment for severe malnutrition in children in Kenya

Official title: Assessing the Impact, Implementation and Cost of Empowering Community Health Promoters to Improve Wasting Treatment Coverage in Turkana County Through Family-led MUAC Scale-up, Weight-for-age Screening, and Defaulters' Follow-up

Run by International Food Policy Research Institute · NCT06441305 · Data updated 2026-11-12

This study is testing a new way to help young children in Kenya who are severely malnourished by using community health workers with smartphones to improve screening and treatment.

More Malnutrition, Child trials

Quick facts

Study typeInterventional
Ages6 Months to 5 Years
SexAll
Enrollment1600 (estimated)
SponsorInternational Food Policy Research Institute
Academic / other
Locations1 site (Lodwar)
StatusRecruiting
StartedJune 3, 2024
Main results expectedJuly 30, 2026
Study endsJuly 30, 2027
Registry record updatedJuly 15, 2026
Trial IDNCT06441305 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 6 to 59.9 months who are identified as severely malnourished based on specific anthropometric measurements.

Probably not a fit

Patients with congenital malformations affecting measurement or those outside the specified height and age criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on addressing severe acute malnutrition (SAM) in children aged 6 to 59.9 months in Kenya by leveraging community health promoters (CHPs) equipped with smartphones and training. The CHPs will use a digitized system to enhance screening and treatment coverage for children with wasting, utilizing tools like mid-upper arm circumference tapes and baby-mother scales. The study will implement a randomized controlled trial design to evaluate the effectiveness of this SWITCH intervention package over two years in selected community units.

Why it matters

Potential benefit: If successful, this approach could significantly increase the identification and treatment of severely wasted children, reducing morbidity and mortality associated with malnutrition.

How similar studies have gone: Previous studies have shown that community-based interventions can effectively improve malnutrition treatment coverage, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Household in a village of the study area covered by a CHP (although the child may or may not be registered by a CHP) AND
* Child is 6-59.9 months of age AND
* Caregiver consents to be part of the study AND
* any of the following:

  * WHZ \< -3 (relative to WHO 2006 reference) OR
  * MUAC \<115 mm OR
  * Presence of bilateral edema OR
  * receiving treatment as follow-up for an initial SAM condition on the way to full recovery

exclusion criteria is:

* Congenital malformation that makes anthropometric measurements impossible.
* Length is below 54 cm or height is above 120cm.

Where it's running

  • Turkana South and Turkana East and Aroo
    Lodwar, Kenya
    Recruiting

Study contacts

  • Principal investigator: Elodie Becquey, PhD — International Food Policy Research Institute
  • Study coordinator: Elodie Becquey, PhD
  • Email: e.becquey@cgiar.org
  • Phone: 778487085

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.